Synthesis Capital Management

Investor

A closeup view of a microscope from a MedTech startup looking into something

A VC Fund investing in medtech from pre-seed to series A+

Synthesis Capital Management, a spin out of the MedTech Actuator, is a VC Fund with a focus on investing in early-stage, deeptech medical, health and wellbeing-related ventures, from pre-seed to series A+.

In August 2024, Synthesis Capital Management received a $300,000 grant to establish in Victoria and back local startups as part of LaunchVic’s VC Support Program. 

Learn more about the fund and how to connect with the team via their website.

Learn more